Magnetic resonance imaging outcomes from a phase III trial of teriflunomide

Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group

    Research output: Contribution to journalArticleScientificpeer-review

    65 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)1310-1319
    JournalMultiple sclerosis journal
    Volume19
    Issue number10
    DOIs
    Publication statusPublished - 2013
    Publication typeA1 Journal article-refereed

    Keywords

    • clinical trial
    • disease-modifying therapy
    • magnetic resonance imaging
    • multiple sclerosis
    • phase III
    • teriflunomide

    Publication forum classification

    • Publication forum level 1

    Cite this